Deflazacort
Deflazacort is an active ingredient in 53 FDA-listed drug products sold under 7 names.
Drugs containing Deflazacort
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 60219-2284 | Deflazacort Tablet | 30 mg/1 | Amneal Pharmaceuticals NY LLC |
| 60219-2282 | Deflazacort Tablet | 6 mg/1 | Amneal Pharmaceuticals NY LLC |
| 60219-2285 | Deflazacort Tablet | 36 mg/1 | Amneal Pharmaceuticals NY LLC |
| 60219-2283 | Deflazacort Tablet | 18 mg/1 | Amneal Pharmaceuticals NY LLC |
| 59651-601 | Deflazacort Tablet | 30 mg/1 | Aurobindo Pharma Limited |
| 59651-600 | Deflazacort Tablet | 18 mg/1 | Aurobindo Pharma Limited |
| 59651-602 | Deflazacort Tablet | 36 mg/1 | Aurobindo Pharma Limited |
| 59651-599 | Deflazacort Tablet | 6 mg/1 | Aurobindo Pharma Limited |
| 73190-069 | Deflazacort Tablet | 18 mg/1 | AvKARE |
| 73190-068 | Deflazacort Tablet | 6 mg/1 | AvKARE |
| 73190-070 | Deflazacort Tablet | 30 mg/1 | AvKARE |
| 73190-071 | Deflazacort Tablet | 36 mg/1 | AvKARE |
| 81806-208 | Deflazacort Tablet | 36 mg/1 | Doppel Farmaceutici S.r.l. |
| 81806-207 | Deflazacort Tablet | 30 mg/1 | Doppel Farmaceutici S.r.l. |
| 81806-204 | Deflazacort Tablet | 6 mg/1 | Doppel Farmaceutici S.r.l. |
| 81806-206 | Deflazacort Tablet | 18 mg/1 | Doppel Farmaceutici S.r.l. |
| 70095-040 | Deflazacort Tablet | 6 mg/1 | Sun Pharmaceutical Industries, Inc. |
| 70095-042 | Deflazacort Tablet | 30 mg/1 | Sun Pharmaceutical Industries, Inc. |
| 70095-043 | Deflazacort Tablet | 36 mg/1 | Sun Pharmaceutical Industries, Inc. |
| 70095-041 | Deflazacort Tablet | 18 mg/1 | Sun Pharmaceutical Industries, Inc. |
| 0832-0815 | Deflazacort Tablet | 18 mg/1 | Upsher-Smith Laboratories, LLC |
| 0832-0816 | Deflazacort Tablet | 30 mg/1 | Upsher-Smith Laboratories, LLC |
| 0832-0817 | Deflazacort Tablet | 36 mg/1 | Upsher-Smith Laboratories, LLC |
| 0832-0814 | Deflazacort Tablet | 6 mg/1 | Upsher-Smith Laboratories, LLC |
| 70710-2053 | Deflazacort Tablet | 30 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-2054 | Deflazacort Tablet | 36 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-2052 | Deflazacort Tablet | 18 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-2051 | Deflazacort Tablet | 6 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 27808-249 | Deflazacort Oral Suspension Suspension | 22.75 mg/mL | Cranbury Pharmaceuticals, LLC |
| 81806-200 | Deflazacort Oral Suspension Suspension | 22.75 mg/mL | Doppel Farmaceutici S.r.l. |
| 57664-993 | Deflazacort Oral Suspension Suspension | 22.75 mg/mL | Sun Pharmaceutical Industries, Inc. |
| 70710-2007 | Deflazacort Oral Suspension Suspension | 22.75 mg/mL | Zydus Pharmaceuticals (USA) Inc. |
| 52856-501 | Emflaza Tablet | 6 mg/1 | PTC Therapeutics, Inc. |
| 52856-502 | Emflaza Tablet | 18 mg/1 | PTC Therapeutics, Inc. |
| 52856-504 | Emflaza Tablet | 36 mg/1 | PTC Therapeutics, Inc. |
| 52856-505 | Emflaza Suspension | 22.75 mg/mL | PTC Therapeutics, Inc. |
| 52856-503 | Emflaza Tablet | 30 mg/1 | PTC Therapeutics, Inc. |
| 81806-177 | Jaythari Tablet | 36 mg/1 | Doppel Farmaceutici S.r.l. |
| 81806-175 | Jaythari Tablet | 18 mg/1 | Doppel Farmaceutici S.r.l. |
| 81806-174 | Jaythari Tablet | 6 mg/1 | Doppel Farmaceutici S.r.l. |
| 81806-176 | Jaythari Tablet | 30 mg/1 | Doppel Farmaceutici S.r.l. |
| 70710-1751 | Jaythari Tablet | 30 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1750 | Jaythari Tablet | 18 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1752 | Jaythari Tablet | 36 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 70710-1749 | Jaythari Tablet | 6 mg/1 | Zydus Pharmaceuticals (USA) Inc. |
| 81806-213 | JAYTHARI Oral Suspension Suspension | 22.75 mg/mL | Doppel Farmaceutici S.r.l. |
| 70710-2131 | JAYTHARI Oral Suspension Suspension | 22.75 mg/mL | Zydus Pharmaceuticals (USA) Inc. |
| 0245-0816 | Kymbee Tablet | 30 mg/1 | Upsher-Smith Laboratories, LLC |
| 0245-0814 | Kymbee Tablet | 6 mg/1 | Upsher-Smith Laboratories, LLC |
| 0245-0813 | Kymbee Suspension | 22.75 mg/mL | Upsher-Smith Laboratories, LLC |
| 0245-0815 | Kymbee Tablet | 18 mg/1 | Upsher-Smith Laboratories, LLC |
| 0245-0817 | Kymbee Tablet | 36 mg/1 | Upsher-Smith Laboratories, LLC |
| 73289-0089 | Pyquvi Suspension | 22.75 mg/mL | Aucta Pharmaceuticals, Inc. |